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Background: As a cellular energy sensor, the 5’AMP-activated protein kinase (AMPK) is activated in response to
energy stresses such as hypoxia and muscle contraction. To determine effects of iron deficiency on AMPK activation
and signaling, as well as the AMPK subunit composition in skeletal muscle, rats were fed a control (C=50-58 mg/kg
Fe) or iron deficient (ID=2-6 mg/kg Fe) diet for 6–8 wks.
Results: Their respective hematocrits were 47.5% ± 1.0 and 16.5% ± 0.6. Iron deficiency resulted in 28.3% greater
muscle fatigue (p<0.01) in response to 10 min of stimulation (1 twitch/sec) and was associated with a greater
reduction in phosphocreatine (C: Resting 24.1 ± 0.9 μmol/g, Stim 13.1 ± 1.5 μmol/g; ID: Resting 22.7 ± 1.0 μmol/g,
Stim 3.2 ± 0.7 μmol/g; p<0.01) and ATP levels (C: Resting 5.89 ± 0.48 μmol/g, Stim 6.03 ± 0.35 μmol/g; ID: Resting
5.51 ± 0.20 μmol/g, Stim 4.19 ± 0.47 μmol/g; p<0.05). AMPK activation increased with stimulation in muscles of C
and ID animals. A reduction in Cytochrome c and other iron-dependent mitochondrial proteins was observed in ID
animals (p<0.01). The AMPK catalytic subunit (α) was examined because both isoforms are known to play different
roles in responding to energy challenges. In ID animals, AMPKα2 subunit protein content was reduced to 71.6% of
C (p<0.05), however this did not result in a significant difference in resting AMPKα2 activity. AMPKα1 protein was
unchanged, however an overall increase in AMPKα1 activity was observed (C: 0.91 pmol/mg/min; ID: 1.63 pmol/mg/
min; p<0.05). Resting phospho Acetyl CoA Carboxylase (pACC) was unchanged. In addition, we observed significant
reductions in the β2 and γ3 subunits of AMPK in response to iron deficiency.
Conclusions: This study indicates that chronic iron deficiency causes a shift in the expression of AMPKα, β, and γ
subunit composition. Iron deficiency also causes chronic activation of AMPK as well as an increase in AMPKα1
activity in exercised skeletal muscle.
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Iron is important for oxygen transport and ATP synthesis.
If these processes are impaired by iron deficiency, cellular
adaptations occur, such as an increased glucose depen-
dence, in response to that deficiency [1,2]. The 5’AMP-
activated protein kinase (AMPK) has been characterized
as a major cellular energy sensor [3], which may mediate
some of these adaptations. AMPK is activated in response* Correspondence: chad_hancock@byu.edu
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reproduction in any medium, provided the orto energy challenges such as hypoxia, muscle contraction,
and hypoglycemia. Therefore, because AMPK is central to
how cells respond to changes in the energy status of the
cell and iron homeostasis is critical for the transduction of
energy within the cell, we set out to investigate the effects
of iron deficiency on AMPK activation and signaling.
Ultimately we believe that this information may help elu-
cidate why specific cellular responses occur with changes
in cellular iron status.
Iron deficiency is the most common worldwide nutrient
deficiency. Of the world’s total population, 24.8% of indivi-
duals are anemic [4]. Anemia occurs at all stages of the lifeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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most prevalent in pregnant women and young children
(41.8% and 47.4% respectively) [4]. Iron deficiency is a
metabolic stress because it compromises both the capacity
for oxygen supply to tissues (anemia), as well as the cap-
acity to utilize oxygen due to impairment of mitochondrial
capacity [5]. This type of energetic stress, due to either
decreased oxygen supply or utilization, has been shown to
cause an increase in AMPK activation [6].
AMPK is a cellular energy sensor that when activated,
stimulates catabolic processes that increase ATP synthesis,
and concurrently inhibits anabolic processes that consume
ATP [7]. Nutritional or environmental stress, such as
hypoglycemia, hypoxia, and/or muscle contraction, lead to
an increase in the AMP:ATP ratio [8]. The function of the
enzyme is altered by the interaction of the AMPK subu-
nits as conformational changes occur. AMPK is a hetero-
trimer consisting of one alpha catalytic subunit and two
regulatory subunits, beta and gamma [9], and multiple iso-
forms of all subunits have been identified (α1, α2, β1 ,β2,
γ1, γ2, γ3) [10,11]. AMPK complexes containing the α2
isoform are more sensitive to changes in AMP concentra-
tion than are complexes containing α1 [12]. Furthermore
each isoform of the α subunit affects different downstream
signaling pathways. For example, the α1 subunit is more
important in the inhibition of protein synthesis via the
mTOR pathway [13,14]. The activation of AMPK is largely
determined by phosphorylation of Thr172 on the α sub-
unit, which causes a greater than 20-fold increase in activ-
ity [3]. This is primarily done by the predominant AMPK
kinase in skeletal muscle, LKB1 [15,16], and is enhanced
when the AMP:ATP ratio is high by nucleotide binding to
the γ subunit of AMPK [17]. Binding of AMP to the γ
subunit increases activation of AMPK by up to fivefold,
but also makes AMPK a poorer substrate for the phos-
phatase and increases phosphorylation by LKB1 (a net in-
crease in activity of >1000-fold) [18,19]. Conversely, when
the AMP:ATP ratio is low, the nucleotide binding sites on
γ are occupied by ATP, eliminating inhibition of the phos-
phatase, decreasing net enzymatic activity [20].
Exercise is a metabolic stress on the cell, which has been
shown to increase the activation of AMPK [21,22]. Muscle
contraction during exercise increases the AMP:ATP ratio
because excitation-contraction coupling depends on the hy-
drolysis of ATP to ADP as its source of energy. Myokinase
catalyzes a reaction that transfers a phoshoryl group from
one ADP to another, which regenerates one ATP, and
forms one AMP (2 ADP→ ATP + AMP). This reaction is
important for limiting the increase in ADP when the rate
of ATP hydrolysis is high, and thus results in an increase
in the AMP:ATP ratio [3,23,24]. The concerted effects of
iron deficiency and muscle contraction on AMPK activa-
tion however are still unknown. A muscle cell that is meta-
bolically stressed due to iron deficiency may be even moreadversely affected by exercise than an iron sufficient cell.
This increased stress likely has consequences on AMPK
activation and signaling.
The effects of hypoxia on AMPK activation have been
documented [25], as well as the adverse effects of iron defi-
ciency on mitochondrial enzyme content [5,26,27], and
AMPK phosphorylation due to iron deficiency [6]. The ob-
jective of this study was to examine: 1) the extent to which
chronic AMPK activation occurs due to iron deficiency, 2)
how AMPK activation and signaling due to muscle stimu-
lation is affected during iron deficiency, and 3) the effects
of iron deficiency on the AMPK subunit composition in
skeletal muscle.
Results
Degree of iron deficiency
Animals fed a diet deficient in iron content became
anemic by 6 weeks of feeding. This was evident by a sig-
nificant reduction of both hematocrit and hemoglobin
(Figures 1A and 1B).
Body Mass. Mean body mass of both C and ID groups
were not different on day 0 of treatment at 21 days of age.
On day 11, the mean body mass of the C group was 20%
greater than that of the ID group. Due to this large dispa-
rity between the two groups we began pair feeding the C
group to the ID group on day 13. The C group continued,
however, to grow at a higher rate than the ID group. After
6 weeks of treatment, the majority of that being pair feed-
ing, the mean body mass of the C group was 282 ± 3 g,
while that of the ID group was 167 ± 5 g (Figure 2). The
ratio of the tibialis anterior muscle mass to the body mass
was measured to determine whether growth of the skeletal
muscle was proportionate to total body growth. This ratio
was not different between the two groups (C: 1.86 mg
muscle weight/g body weight ± 0.06; ID: 1.87 mg muscle
weight/g body weight ± 0.03).
Effect of iron deficiency on mitochondrial enzyme
expression
The electron transport chain (ETC.) of the mitochondria
depends on iron as an electron acceptor/donor at multiple
steps of electron transport. Cytochrome c, Cytochrome c
oxidase I (COX1), and Succinate Dehydrogenase are all
iron-dependent enzymes of the ETC. Because they depend
on iron for enzymatic activity, it would be expected that
their protein content would decrease with iron deficiency.
All three of these enzymes decreased significantly with
iron deficiency (p<0.01) (Figure 3), confirming that iron
deficiency created a situation of significant energy insult.
Skeletal muscle fatigue
It has been shown that muscle contraction causes an in-
crease in AMPK activity [28]. In order to further show
differences in AMPK activation due to iron deficiency,
Figure 1 Plasma hematocrit and hemoglobin concentration. A. Hematocrit decreased dramatically with iron deficiency (ǂ indicates statistical
significance, p<0.01) (n=4). B. Hemoglobin concentration decreased significantly with iron deficiency (ǂ indicates statistical significance,
p<0.01) (n=4).
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Figure 2 Mean body mass of control and iron deficient groups.
The rate of growth of the ID group was beginning to decrease by
the end of the treatment period, whereas the C group did not show
a decrease in growth rate. The mean body mass of the C group was
significantly greater than the ID group by day 10 of treatment
(p<0.01). A difference that continued to increase throughout the
treatment period (n=15).
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with a low-demand stimulation protocol similar to ours,
oxygen has been supplied during muscle stimulation, and
C rats showed little or no fatigue [29]. Therefore, in the
present study, oxygen was supplied to both the C and ID
groups to limit the oxygen deficit due to anemia and in-
crease our ability to focus on muscle specific effects of
iron deficiency. Evidence that this approach was successful
in limiting the hypoxia of the control rats includes: 1) the
resting concentration of phosphocreatine was not different
between C and ID muscles and 2) a difference in AMPK
activity under these conditions was not observed at rest,
as others have shown [6]. Although this did serve to limit
the oxygen deficit, it did not eliminate it completely.
Hemoglobin concentration in the ID rats was reduced by
about half, meaning that the ID rats only had about 50%
of the oxygen carrying capacity of the C rats. Even with
supplementation of 100% oxygen, the ID rats during
stimulation were likely hypoxic compared to the C rats.
The mean initial force generated by the C group was
39% greater than that generated by the ID group (C: 601 ±
42 g; ID: 433 ± 34 g). Although the mean body mass of
the C group was greater, the amount of force generated by
the right hindlimb GPS complex per gram of muscle mass
was not different between the two groups (C: 0.24 ± 0.03
g/mg muscle; 0.32 ± 0.04 g/mg muscle). In order to
analyze relative fatigue, force data was analyzed as a per-
cent of the initial force generated by each group during
the 10 minutes of stimulation. Although within the first
1–2 minutes of stimulation, the amount of force gener-
ated by the two groups increased, the force generated
by the ID group dropped to 72% of the initial force
after 10 minutes of stimulation, whereas the C group was
able to generate 100% of the initial force by the end of the
same 10-minute period (Figure 4). Thus, this stimulation
protocol was mild enough to limit any net fatigue in the
control rats over the course of 10 minutes.
High energy phosphates
Aside from the major mechanisms of ATP synthesis
from carbohydrate and fatty acid substrates, the concen-
tration of ATP is buffered through the creatine kinasesystem. In addition, an increase in the concentration of
ADP during exercise is limited by the myokinase reaction
(2ADP ←→ ATP + AMP), resulting in an increase in
AMP. Much of that AMP is then converted to IMP by
AMP deaminase. This buffering action by creatine kinase
and myokinase as well as the continual supply of ATP
from oxidative phosphorylation limits any net reduction
in ATP under most energy demands. During high energy
demands, muscle AMP and IMP increase, while ATP and
phosphocreatine decrease. The purpose of measuring the
concentration of high-energy phosphates in these muscles
tissues was to determine and compare the cellular energy
state of the ID and C groups. An increase in ADP and
AMP, is associated with activation of AMPK [30].
Phosphocreatine levels decreased in the C group by
45.9% during the 10-minute stimulation period. In the ID
group however, phosphocreatine levels were reduced by
85.9% (Table 1). IMP concentration increased modestly in
C rats during stimulation (3.6-fold), but increased by a
much larger amount in ID rats (8.7-fold) (Table 1). There




















































































Figure 3 Abundance of mitochondrial proteins in
gastrocnemius muscle. Iron-containing proteins of the electron
transport chain are expected to decrease with iron deficiency.
A. Cytochrome c protein levels decreased dramatically with iron
deficiency (p<0.01). B. COX1 protein levels decreased dramatically
with iron deficiency (p<0.01). C. Succinate dehydrogenase protein
levels were undetectable in tissues of ID animals. Since below 2
arbitrary units would have been considered to be significantly
different, it can be concluded that the reduction in succinate
dehydrogenase was statistically significant.
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Figure 4 Force of muscle contraction. Fatigue was much greater
in the ID group as evidence by the drop off in force that they were
able to generate after continued 1 Hz muscle stimulation. After 6
min 40 sec the amount of force generated by the C rats was
significantly greater than that of the ID rats (p<0.01) (n=11-14).
Table 1 High energy phosphate concentrations in
gastrocnemius muscle
Control Iron Def
Rest Stim Rest Stim
ATP (n=6-8) 5.89 ± 0.48 6.03 ± 0.35 5.51 ± 0.20 4.19 ± 0.47ǂ
ADP (n=6-8) 0.79 ± 0.08 0.96 ± 0.07 0.73 ± 0.03 1.03 ± 0.07
AMP (n=6-8) 0.06 ± 0.01 0.09 ± 0.02 0.05 ± 0.00 0.16 ± 0.06
IMP (n=6-8) 0.22 ± 0.01 0.80 ± 0.30 0.26 ± 0.02 2.26 ± 0.63ǂ
PCr (n=9-10) 24.1 ± 0.9 13.1 ± 1.5 22.7 ± 1.0 3.2 ± 0.7ǂ
Cr (n=9-10) 15.8 ± 1.1 28.3 ± 2.3 19.2 ± 0.9 37.0 ± 1.8ǂ
Values are means ± SE in α mol/g wet wt. PCr, phosphocreatine; Cr, creatine.
ǂ Significantly different from control (p<0.01).
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0.17 ± 0.09 nmol/g wet wt in ID compared to control
muscles), which approached statistical significance
(p=0.05). These data confirm that while the stimulation
protocol was mild (no net fatigue in the controls) the iron
deficient rats sustained a much greater challenge to the
energy state.Analysis of AMPK activation
After establishing that the ID rats were iron deficient and
that this did create a metabolic stress, we examined the
effects of chronic iron deficiency and in situ muscle stimu-
lation on activation of the two AMPKα isoforms. In ac-
cordance with previous findings [21,22], the overall effect
of stimulation was a significant increase in activation of
both AMPKα isoforms in both the C and ID groups. The
two AMPKα isoforms, however, were affected differently
by iron deficiency. Although it has been shown to be more
AMP-dependent than AMPKα1 [12], resting AMPKα2 ac-
tivity was not significantly different between the C and ID
groups (Figure 5A). Iron deficiency however did cause an
increase in resting AMPKα1 activity which approached stat-
istical significance (p=0.05). Also, activation of AMPKα1 did
not increase significantly due to stimulation in the C
group alone, but in the ID group, stimulation did result
in a significant increase in AMPKα1 activation (p=0.05)
(Figure 5B).
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of the expression of phosphoAMPK to total AMPKα is
also a reflection of total AMPK activation. This ratio did
not increase significantly due to iron deficiency. It did,
however increase with stimulation of both the C and ID
groups (Figure 5C).
Acetyl CoA Carboxylase (ACC) is a downstream sub-
strate of AMPK, and is inhibited by phosphorylation. The
ratio of expression phosphoACC to total ACC was there-
fore used as an additional indicator of AMPK activation.
Although ACC phosphorylation did increase greatly with
stimulation, it did not increase significantly in rested tis-
sues with iron deficiency (Figure 5D).
Analysis of AMPK subunit expression
Alpha subunits:AMPK complexes containing the α2 iso-
form sense and respond differently to energy stresses than
AMPK complexes containing the α1 isoform. AMPKα2 is
more sensitive to changes in AMP concentration than
AMPKα1 [12]. AMPKα2 protein content decreased sig-
nificantly (p<0.05) (Figure 6A), while AMPKα1 did notFigure 5 Acute activation of AMPK in gastrocnemius muscle. A. AMPKα2 a
increased with stimulation in both C and ID groups (* indicates statistical signific
with iron deficiency. AMPKα1 activity in stimulated limb did increase with iron d
not increase with muscle stimulation in the C rats, whereas it did increase with
C. Total AMPK phosphorylation did not significantly increase with iron deficienc
statistical significance, p=0.05) and ID groups (ǂ indicates statistical significance,
not significantly increase with iron deficiency, but did increase with stimulationchange significantly (Figure 6B). These data suggest a
slight shift in the AMPKα subunit composition due to the
chronic stress of iron deficiency. A non-isoform-specific
AMPK pan α antibody was also used to quantitate expres-
sion of total AMPK, which was determined to be un-
changed with iron deficiency (Figure 6C). Beta and gamma
subunits: In addition to the α subunit expression, we also
examined the expression of the regulatory β and γ subunits.
While there were no differences in the expression of the
β1, γ1 and γ2 subunits (Figure 7A, C and D), there was a
significant reduction in both the β2 (Figure 7B) and γ3
(Figure 7E) subunits in response to severe iron deficiency.Chronic activation of AMPK
Treatment with AICAR (a chemical activator of AMPK)
has been shown to increase expression of Hexokinase II in
skeletal muscle [31]. Therefore, we examined Hexokinase
II expression as an indicator of chronic AMPK activation
and found it to be increased dramatically with iron defi-
ciency (p<0.01) (Figure 8A).ctivity in resting limb did not increase with iron deficiency. AMPKα2
ance, p<0.05) (n=9-10). B. AMPKα1 activity in resting limb did not increase
eficiency (ǂ indicates statistical significance, p<0.01). Also, activity of α1 did
stimulation in the ID rats (* indicates statistical significance, p=0.05) (n=8-10).
y. It did however increase with stimulation in both the C (* indicates
p<0.01) (n=3-4). D. Phosphorylation of ACC, a direct target of AMPK, did
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0.4
Figure 6 AMPK alpha subunit expression in gastrocnemius
muscle with iron deficiency anemia. A. AMPKα2 protein content
decreased with iron deficiency (* indicates statistical significance,
p<0.05) (n=5-6). B. AMPKα1 protein content was not different
between the two groups (n=8). C. Total AMPK pan α protein
content did not change with iron deficiency (n=4). The decrease in
total AMPKα is not surprising given that α2 is the more abundant
isoform found in skeletal muscle. The decrease in α2, with no
concurrent decrease in α1 indicates a slight shift in α subunit
composition due to iron deficiency.
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cycle. It can be upregulated by chronic activation of
AMPK. Western blot data for citrate synthase revealed
that its expression was not changed with iron deficiency
(Figure 8B). Citrate synthase activity data also revealed no
change with iron deficiency (Figure 8C).
Discussion
AMPK is a key regulator of cellular energy homeostasis. It
becomes activated by various energy challenges which re-
sult in an increase in the AMP:ATP ratio. Iron deficiency
is one such energy challenge. It results in a decrease in the
iron-containing enzymes of the electron transport chain,
without affecting the non-iron dependent enzymes of the
citric acid cycle [27]. These changes lead to a decrease in
muscle respiratory capacity as well as increased suscepti-
bility to fatigue [26]. The ability of AMPK to sense ener-
getic insults such as this leads to the question as to
whether its activity increases, and how its expression and
signaling are affected during iron deficiency. Following
6–8 weeks of treatment, AMPKα2 expression in ID ani-
mals was reduced significantly compared to C (p<0.05).
AMPKα1 expression was not different as a result of iron
deficiency. Under the conditions in this study, iron defi-
ciency did not result in a difference in resting AMPKα2
activity. Interestingly, iron deficiency did cause an increase
in resting AMPKα1 activity, which approached statistical
significance (p=0.05). Also, muscle stimulation did not re-
sult in increased activation of AMPKα1 in the C group,
but in the ID group, stimulation did result in a significant
increase in AMPKα1 activity (p=0.05). When the β and γ
subunits were examined, significant reductions were
observed in both the β2 and γ3 subunits of AMPK. The
novel findings of this study are that chronic iron defi-
ciency causes a shift in the expression of AMPKα, β and γ
subunit composition as well as potentially altered sensitiv-
ity of AMPKα1 and AMPKα2 to energy challenges such
as muscle contraction.
Iron deficiency anemia causes a shift in AMPK subunit
composition
Muscle contraction in ID rats resulted in a greater increase
in AMPKα1 activation than in C rats. Increased AMPK
phosphorylation, or covalent activation of AMPK, occurs
when an increase in the AMP:ATP ratio results in AMP
binding to the γ subunit. More recent work has also pro-
posed a role for ADP in addition to AMP in the allosteric
regulation of AMPK (see recent review by Hardie, Carling
and Gamblin [30]). AMP binding directly to the γ subunit
results in allosteric activation of AMPK, which alone,
increases activity by up to fivefold [18]. AMPKα2 is more
responsive to an increase in the concentration of free
AMP (AMPf) than AMPKα1 [12]. In our calculation of
the difference of AMPf concentration between C and ID
Figure 7 AMPK beta and gamma subunit expression following irion deficiency anemia in rat gastrocnemius muscle. A. AMPK b1 subunit
expression was not different in response to iron deficiency. B. AMPK b2 subunit expression was reduced with iron deficiency in response to iron
deficiency (p<0.01). No changes were observed with AMPK g1 (C) or g2 (D) subunit expression in response to iron deficiency, however a marked
reduction was observed with g3 subunit expression (p<0.001) (E).
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tical significance because of the large variability between
samples. An increase in AMPf concentration however, can
be assumed based on the significant increase in IMP con-
centration, since IMP is a product of AMP deamination.
Interestingly, we did not see a change in AMPKα2 activity
with iron deficiency, even though the HPLC data confirms
an increase in the concentration of IMP in the iron defi-
cient, stimulated muscles. Of particular interest is the
finding that AMPKα1 activity did increase with iron defi-
ciency. Therefore, there is an apparent inconsistency with
the energy status and the AMPK activity data. The proto-
col used to assess AMPK activity however, fails to reflect
the allosteric activation of AMPK that is to be expected
with the elevated levels of IMP and AMPf that were seen
in the ID rats following muscle stimulation. Unlike our
in vitro method of measuring AMPK activity, measuring
phosphorylation of ACC should account for the allosteric
activation of AMPK, as this is a method of measuring total
in vivo AMPK activity. However, protein analyses indicate
that muscle stimulation in the ID rats did not cause a
greater increase in ACC phosphorylation than in C rats.
This suggests that the reasons for the increase in
AMPKα1 activity with muscle stimulation in the ID group
may be due to more than just the change in energy status.
One possible explanation is the fact that AMPKα1 activity
has been shown to increase with overload of the plantaris
muscle in LKB1−/− mice, with a concurrent increase in
CaMKK activity [32]. This suggests that AMPKα1 is the
preferred target for CaMKK, a known upstream kinase of
AMPK. Further testing to determine if CaMKK activationis altered due to iron deficiency is necessary in order to
confirm this assumption.
Since activation of AMPKα1 increased significantly
with stimulation in ID animals, we conclude that there
may be an increase in the contribution of AMPKα1 to
total AMPK activity with iron deficiency. This is not to
say that the contribution of AMPKα1 became greater
than that of AMPKα2 to total AMPK activity (AMPKα2
activity still increased more with stimulation in the ID
group than AMPKα1 activity). AMPKα1 simply became
more responsive to stimulation in the ID group than it
was in the C group. This increase in AMPKα1 contribu-
tion to total AMPK activity is further confirmed by the
finding that AMPKα2 expression decreased with iron
deficiency, whereas AMPKα1 expression did not change.
Together, these data indicate that iron deficiency may
cause a shift toward AMPKα1 having a greater role in
the activity of AMPK in skeletal muscle.
In addition to the alpha subunit composition, the com-
position of the β and γ also determine how AMPK res-
ponds to energy stress as well as what downstream
effectors are regulated. The heterotrimeric composition
that is primarily activated in skeletal muscle is the α2/β2/
γ3 combination [33-35]. We report that along with a re-
duction in the α2 subunit isoform, there is also a marked
reduction in the α2 and γ3 subunit isoforms in response
to iron deficiency. Previous reports looking at changes in
the heterotrimeric subunit composition of AMPK have
been somewhat mixed. In response to endurance exercise
training in rats, one group has reported fast twitch mus-

















































































Figure 8 Severe iron deficiency, hexokinase and citrate
synthase expression in gastrocnemius muscle. A. Hexokinase
expression increased significantly with iron deficiency (ǂ indicates
statistical significance, p<0.01) (n=6). B. There was no difference in
citrate synthase expression between C and ID groups (n=6). C. There
was no difference in citrate synthase activity between C and ID
groups (n=7-8).
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frequency stimulation induces an increase in both α subu-
nits [37]. In human muscle, exercise training has been
shown to cause an increase in α1, β2 and γ1 subunits and
cause a reduction in the γ3 subunit [38,39]. Interestingly,
recent work examining the role of γ2 subunit of AMPKsuggests that this subunit is critical for AMPK to respond
to changes in energy state [40]. Thus, given the reduction
observed in the β2 subunit with iron deficiency, we might
have expected a blunted response to the energy demands
of muscle contractions; however we did not observe this.
As noted above, the regulatory effect of AMP on AMPK
occurs via binding to the γ subunit. The γ3 isoform has
the lowest AMP dependence and the γ1 isoform has the
greatest AMP dependence [35]. This shift in the gamma
subunit isoform expression that we observed (lower γ3
while maintaining γ1) may contribute to the increase in
the sensitivity to muscle contractions observed with α1 ac-
tivity. Overall, the shift in the protein expression of the
AMPK subunit composition did not result in a dramatic
reduction or increase in AMPK activity at rest or in re-
sponse to muscle contractions.
Evidence of chronic AMPK activation
Han et al. showed that iron deficiency causes chronic acti-
vation of AMPK [6]. This is not surprising since iron defi-
ciency causes a decrease in the oxygen carrying capacity of
blood as well as a decrease in mitochondrial capacity. The
stress that this puts on energy metabolism should be
enough to cause chronic AMPK activation due to the mild
energy demands of normal ambulatory activity. As reflected
by the phosphorylation state of AMPK and ACC however,
we did not measure such an increase in chronic AMPK
activity. This was likely due to the supplementation of the
anesthetized rats with pure oxygen (~40-50 minutes prior
to dissection of rested muscles). Based on previous work,
this is enough time for any elevation in AMPK activity at
rest to return to more normal values [41]. Therefore, due
to the length of time during which rested animals were
provided with pure oxygen, the effects of iron deficiency
on resting muscle AMPK activity were likely masked.
Chronic AMPK activation increases expression of certain
mitochondrial and glycolytic enzymes [31,42]. Hexokinase
II is regulated by CREB, which can also be phosphorylated
by AMPK [43,44]. In support of chronic AMPK activation,
hexokinase II expression did increase with iron deficiency.
In the present study, iron deficiency presents a unique en-
ergy challenge in that many oxidative enzymes of the elec-
tron transport chain, enzymes that are generally increased
by AMPK activation, are iron-dependent, however all iron-
dependent mitochondrial proteins examined were severely
reduced due to iron deficiency. Citrate synthase, a non-
iron dependent mitochondrial enzyme, was not reduced
with iron deficiency. Two possible explanations for this re-
sult are: 1) AMPK was not chronically activated with iron
deficiency, or 2) iron deficiency has an overall negative
impact on mitochondrial content, including transcription
of all mitochondrial proteins, and chronic AMPK activa-
tion actually prevents down-regulation of the non-iron
dependent enzymes, rescuing the cell from complete
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AMPK activation on citrate synthase, further work is
needed to determine if AMPK is playing a role in preser-
ving citrate synthase expression.
A decrease in important mitochondrial enzymes, as seen
in the present study, reflects a significant decrease in
muscle oxidative capacity, and is therefore a possible ex-
planation for the stunted growth seen in the ID rats. Skel-
etal muscles depend on oxidative phosphorylation far
more than any other process for the conversion of nutri-
ents to usable forms of energy. In this case it would be
expected that any ingested nutrients would not be effi-
ciently used for the production of ATP necessary for pro-
tein synthesis and normal growth.
Previous studies have shown that iron deficiency leads
to in increased dependence on glucose metabolism [1,2].
The decrease in mitochondrial proteins seen with iron de-
ficiency in previous [27], as well as in the present study,
support these findings that iron deficiency causes a shift
away from oxidative metabolism. A novel finding shown
here is a significant increase in Hexokinase II expression,
supporting previous findings that iron deficiency causes a
shift toward glycolytic metabolism in order to compensate
for the loss of oxidative capacity. As previously stated,
chronic AMPK activation increases hexokinase II expres-
sion, supporting the idea that AMPK is at least in part re-
sponsible for the shift toward glycolytic metabolism seen
with iron deficiency. A transgenic model in which AMPK
activation is prevented might provide insight into this
question.
Another possible explanation for the stunted growth
seen in the ID rats is the role of AMPK in inhibition of the
actions of mTOR. As previously stated, AMPKα1 is more
important than AMPKα2 in the inhibition of protein syn-
thesis via the mTOR pathway [14,32]. This shift toward
AMPKα1 having a greater role in total AMPKα activity is
another possible explanation for the large difference in
body mass between the C and ID groups. If AMPKα1 pro-
portionally increases with iron deficiency, the mTOR path-
way would be further inhibited in ID animals than in C
animals, causing increased inhibition of protein synthesis,
and therefore decreased growth.
Conclusions
As a cellular sensor and regulator of energy homeostasis,
AMPK senses and responds to many energy challenges,
such as iron deficiency, in a variety of ways. Here we pro-
vide evidence for a chronic increase in AMPK activity. We
also show a decrease in AMPKα2, β2 and γ3 AMPK subu-
nits, with no concurrent change in AMPKα1, β1, γ1 or γ2
proteins, resulting in an overall shift in AMPK subunit
composition. These data suggest that iron deficiency
results in a possible shift toward an increase in the role of
AMPKα1/ β1/γ1 heterotrimer dependent signaling in totalAMPK regulation of cellular energy homeostasis. Iron de-
ficiency also causes a shift away from oxidative and toward
glycolytic metabolism in rat skeletal muscle. Taken to-
gether, these results lead to the question as to whether
AMPK is responsible for the metabolic shift seen with
iron deficiency. Future work needs to be done in order to
determine if such is the case.
Methods
Animals
Male Wistar rats were kept in a temperature controlled
and well-ventilated room with a 12:12 hour light dark
cycle. They were kept in stainless steel mesh wire bottom
cages, with no bedding material, and no access to feces. All
rats were given free access to distilled water. The iron defi-
cient (ID) group was fed ad libitum and the control (C)
group was pair fed to the ID group (see below). All experi-
mental procedures were approved by the institutional ani-
mal care and use committee of Brigham Young University.
Body weight
The rats were weighed 2–3 times per week from the first
day on the diets up to, and including the day of sacrifice.
Treatments
The ID rats were fed an iron deficient diet ad libitum for
6–8 weeks (n=15). The iron deficient diet was obtained
from Teklad Lab Animal Diets (Harlan Laboratories,
Madison, WI), and consisted of: Casein (low Cu & Fe),
DL-methionine, sucrose, corn starch, corn oil, mineral mix
(Fe deficient), vitamin mix, choline bitartrate, ethoxyquin)
(TD.80396, contains approximately 2–6 ppm Fe). The C
rats were fed the same diet with 48 ppm added iron
(TD.80394), pair fed to the ID group for the same period
of time (n=15). All rats were approximately 21 days of age
on day 0 of treatment.
In situ muscle stimulation was performed as described
previously [24]. Briefly, the rat was anesthetized with 60
mg/kg sodium pentobarbital ip and the sciatic nerve was
isolated and stimulated at rate of 1 twitch contraction per
second for 10 minuntes (0.25 ms square wave, 6–7 V,
using Grass S88X stimulator). In order to limit the oxygen
deficit due to reduced hemoglobin in the blood, the
anesthetized rat of both C and ID groups was provided
with 100% oxygen throughout the procedure.
Tissue analysis
Dissections
After 6–8 weeks of treatment and right hind-limb stimu-
lation, gastrocnemius, soleus, plantaris, and mixed quad-
riceps muscles were removed quickly and clamp frozen
with liquid nitrogen chilled metal tongs and stored
at −90°C. The stimulated right hind limb muscles were
removed and frozen prior to the rested left hind limb
Merrill et al. Nutrition & Metabolism 2012, 9:104 Page 10 of 12
http://www.nutritionandmetabolism.com/content/9/1/104muscles. Whole blood was also collected to determine
hemoglobin concentration and percent hematocrit
(described below).
Muscle contractions
In order to examine the response of AMPK to an increase
in energy demands with and without iron deficiency
anemia we performed a mild in situ muscle stimulation
protocol. Muscle contractions were elicited using the
stimulation procedure via direct stimulation of the sciatic
nerve as described previously [24]. This stimulation proto-
col is sufficient to activate all of the muscle fibers that are
innervated by the sciatic nerve. The fatigue profile of the
gastrocnemius-plantaris-soleus (GPS) complex of muscles
was determined in response to a mild contraction proto-
col consisting of direct sciatic nerve stimulation at a rate
of 1 pulse per second. Muscle force was measured using a
force transducer (Grass FT103) and performance data was
collected using data acquisition software (iWORX). Fol-
lowing the muscle stimulations, the aforementioned calf
muscles were quickly dissected from the right hind-limb
and flash-frozen with tongs maintained in liquid nitrogen.
Corresponding muscles in the contra-lateral unstimulated
limb were subsequently dissected and frozen as rested
control muscles.
Homogenization
Frozen gastrocnemius muscles were pulverized in liquid
nitrogen, weighed, and homogenized as a 5% solution in
homogenization buffer (20 mM Tris–HCl, 250 mM
Mannitol, 50 mM NaF, 5 mM Sodium Pyrophosphate, 1
mM EDTA, 1 mM EGTA, 1% Triton X-100, 50 mM β-
glycerophosphate, 1 mM Sodium Orthovanadate, 1 mM
DTT, 1 mM Benzamadine, 0.1 mM PMSF, 5 βg/ml
Soybean Trypsin Inhibitor, pH 7.4) (50 mg muscle pow-
der/1 ml buffer) then stored in −90°C freezer.
Packed cell volume (hematocrit)
Blood was taken from the tail 4 weeks after the start of
feeding, and once weekly after that, to determine degree
of iron deficiency anemia. This was done by drawing
blood into a capillary tube and centrifuging for 5 min at
14,500 rpm.
Protein quantification
The standard Lowry Protein Assay protocol (BioRad,
Hercules, CA) was used to measure the protein concentra-
tion in each muscle homogenate so that an equal amount
of protein was added to each well for electrophoresis.
Hemoglobin quantification
A hemoglobin quantification assay was used to determine
the degree of anemia reached in the ID rats versus the C
rats on the day of sacrifice as previously described [45,46].Briefly, known concentration hemoglobin standards were
made by adding the appropriate amount of hemoglobin to
the appropriate volume of Drabkin’s solution (1 vial of
Drabkin’s reagent with 1000 ml water and 0.5 ml Brij 35
Solution). Abs540nm was recorded and used to make a lin-
ear standard curve. Whole blood samples were diluted 10-
fold in 0.9% NaCl solution. 2.5 ml Drabkin’s solution was
added to a series of test tubes. 10 μl of whole blood sam-
ple was added to each test tube and allowed to sit for 15
min at room temperature. Abs540nm was recorded and
compared with standard curve to determine hemoglobin
concentration of each sample.
AMPK activity assay
An AMPK Activity Assay was used to directly measure
and compare the amount of AMPK that was activated in
the different experimental groups. The protocol used was
described previously [21,47]. Briefly, immunoprecipitation
was performed on spun muscle homogenates in order
to isolate AMPKα1 and AMPKα2 with the appropriate
antibodies (AMPKα1 1:10,000 from Bethyl – cat. no.
A300-507A; AMPKα2 1:4,000 from Bethyl – cat. no.
A300-508A). AMPK activity was quantitated by measu-
ring the rate of incorporation of radiolabeled phosphate
from ATP into an artificial peptide substrate (SAMS) with
a sequence similar to that of liver acetyl-CoA carboxylase,
a natural substrate for AMPK.
Citrate synthase activity assay
A citrate synthase assay was used to measure the differ-
ence in activity of the enzyme between the C group and
the ID group as previously described by Srere [48].
Western Blot
Standard Western blot protocol was used. Western blot
analysis was performed on gastrocnemius muscles for
AMPKα1 (1:10,000 from Bethyl; cat. no. A300-507A),
AMPKα2 (1:4,000 from Bethyl; cat. no. A300-508A), AMPKβ1
(1:4,000 from Cell Signaling; cat. no. 4182), AMPKβ2 (1:4,000
from Cell Signaling; cat. no. 4148), AMPKγ1 (1:4,000
from Cell Signaling; cat. no. 4187), AMPKγ2 (1:2,000 from
Santa Cruz; cat. no. 20165), AMPKγ3 (1:2,000 custom made
from Affinity Bioreagents), AMPK pan α (1:2,000 from Cell
Signaling; cat. no. 2532L), phosphoAMPKα (1:1,000 from Cell
Signaling; cat. no. 4188L), ACC (1:2,000 from Cell Signaling;
cat. no. 3662), phosphoACC (1:5,000 from Cell Signaling;
cat. no. 3661S), hexokinase II (1:10,000 from Santa Cruz; cat.
no. sc-6521), myoglobin (1:3,000 from Santa Cruz; cat. no. sc-
25607), cytochrome c oxidase complex 1 (COX-1) and suc-
cinate dehydrogenase (1,5:000 OxPhos Cocktail Ab from Invi-
trogen; cat. no. 458009), and cytochrome c (1:5,000 from
Sigma; cat. no. C5723). Western blot analysis was also per-
formed on mixed quadriceps muscle for citrate synthase
(1:10,000 from Alpha Diagnostic; cat. no. CISY11-A).
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Preparation of tissues for HPLC were done using the
Perchlorate Tissue Extraction method as described by
Chen [49]. Briefly, muscles were ground to powder at li-
quid nitrogen temperature and then homogenized in
3.5% perchloric acid in a volume 19 times the wet weight
of the muscle. The homogenates were then centrifuged at
12,000 rpm for 7 min to remove protein. This was followed
by neutralization of the supernatant with tri-n-octylamine
and 1,1,2-trichlorotrifluoroethane. After vortexing for 1
min, the neutralized homogenates were again centrifuged
at 2,000 rpm for 7 min. The top phase was saved, checked
for pH (it should be between 5.5-6.5), and stored at −80°C.
Adenine nucleotides (ATP, ADP, AMP) and IMP were
quantified by reverse-phase HPLC, as described by Tullson
et al. [50]. Phospocreatine (PCr) and creatine (Cr) concen-
trations were measured by ion exchange HPLC as
described by Wiseman and colleagues [51].
Free ADP ([ADPf]) and free AMP concentrations
([AMPf]) were estimated based on the following equations
ADPf½  ¼ ATP½  creatine½ =Kobs Hþ½  phosphocreatine½ 
where Kobs = 1.66 × 10
-6 mM-1, and assuming 76% water,
and 14% vascular volume [52]
AMPf½  ¼ ADPf½ 2=Kobs ATP½ 
where Kobs = 1.05 × 10 [53]. pH was assumed to be 7 in
rested animals [53] however based on the differences in
phosphocreatine, fatigue, and IMP accumulation, we esti-
mated pH to be 6.6 in the C animals following stimulation
and 6.2 in the ID animals following stimulation [53].
Statistics
For comparisons including iron deficiency and muscle
stimulation (4 different groups) two-way analysis of vari-
ance was used. Fisher’s least significant difference post-hoc
test was applied where appropriate. When making a sim-
ple comparison between ID and C a student’s t-test was
used. SigmaStat statistical software was used. Statistical
significance is defined as p<0.05. Results are presented as
means ± SEM.
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